MGLL and neurodegenerative disease: Ren Ren S-y S-y Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases—focusing on FAAH/MAGL inhibitors Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases—focusing on FAAH/MAGL inhibitors Acta Pharmacol Sin Acta Pharmacol Sin 2020 2020 41 41 10 10 1263 1263 1271 1271 10.1038/s41401-020-0385-7 10.1038/s41401-020-0385-7 supplied-pmid 32203086?